ArticleBMJ open2016
Epidemiology of cancers in Lahore, Pakistan, 2010-2012: a cross-sectional study.
Article in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- National cervical cancer burden estimation through systematic review and analysis of publicly available data in Pakistan.BMC public health · 2023Pooled it
- Epidemiology and treatment patterns for locally advanced or metastatic urothelial carcinoma: a systematic literature review and gap analysis.Journal of managed care & specialty pharmacy · 2021Pooled it
- Incidence trend of breast Cancer in women of eastern Mediterranean region countries from 1998 to 2019: A systematic review and meta-analysis.BMC women's health · 2020Pooled it
- Cancer prevalence in Pakistan: meta-analysis of various published studies to determine variation in cancer figures resulting from marked population heterogeneity in different parts of the country.World journal of surgical oncology · 2018Pooled it
- Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial.European journal of nuclear medicine and molecular imaging · 2019Trial
- Differences in the incidence and mortality of tracheal, bronchus, and lung cancer between the Global Cancer Observatory 2022 and the Global Burden of Disease 2021.Journal of the National Cancer Center · 2025Article
- Predominance of MGMT promoter methylation among Pakistani glioblastoma patients.Molecular biology reports · 2024Article
- Article
- Basic Findings of Incidence of Breast Cancer in Allied Hospital Faisalabad, Pakistan: A Retrospective Study.Iranian journal of public health · 2023Article
- Cancer Registration in Pakistan: a Reality Check.Journal of cancer & allied specialties · 2022Article
- Cancer in Lahore, Pakistan, 2010-2019: an incidence study.BMJ open · 2021Article
- Absence ofFrontiers in oncology · 2021Article
- Article
- Proteomics analysis of colon cancer progression.Clinical proteomics · 2019Article
- Exploring the Causes of the Low Incidence of Cervical Cancer in Western AsiaAsian Pacific journal of cancer prevention : APJCP · 2018Article
- Epidemiology of renal cancer in developing countries: Review of the literature.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2018Review
- Epidemiology of cancers in Lahore, Pakistan, among children, adolescents and adults, 2010-2012: a cross-sectional study part 2.BMJ open · 2017Article
- Pattern of gynaecological malignancies in south western region of Pakistan: An overview of 12 years.Biomedical reports · 2017Article
- Colorectal Cancer Screening Knowledge and Associated Willingness and Barriers to Screening in Nationwide Pakistan Cohort.Euroasian journal of hepato-gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo estimate the population-level cancer estimates for the Lahore district, which is part of the Punjab Cancer Registry (PCR), Pakistan. The average population per year of Lahore was estimated at 9.8 million in 2010-2012.
designA cross-sectional study.
settingThe Registry has 19 collaborating centres in Lahore that report their data to the Central Office located within a tertiary care cancer treatment facility in Lahore, Pakistan.
participantsPatients belonging to Lahore, of any age-group, and diagnosed with cancer in 2010-2012, were included in the study. They were followed up between July and October 2015 to determine their vital status. OUTCOME MEASURES: Summaries were generated for gender, the basis of diagnosis, diagnoses and deaths. The Age-Standardized Incidence Rates (ASIR) were computed per 100 000 population, by gender and cancer site. Five-year age categories were created from 0-4 until 70-74, followed by 75+ years. Death counts were reported by site.
resultsBetween 2010 and 2012, in Lahore, a total of 15 840 new cancers were diagnosed in 43% male patients and 57% female patients; 93.5% were microscopically confirmed and 6.5% non-microscopically. In females, the ASIR was 105.1 and in males, it was 66.7. ASIRs of leading cancers among women were breast 47.6, ovary 4.9 and corpus uteri 3.6, whereas among men they were prostate 6.4, bladder 5.0, and trachea, bronchus and lung 4.6. A total of 5134 deaths were recorded.
conclusionsIn Lahore, the ASIR was higher in women than in men. Among women and men, breast cancer and prostate cancer, respectively, were the leading cancer types. These estimates can be used for health promotion and policymaking in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.